248 related articles for article (PubMed ID: 18650258)
1. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
[TBL] [Abstract][Full Text] [Related]
2. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
[TBL] [Abstract][Full Text] [Related]
3. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin.
Thors L; Koch M; Wigenstam E; Koch B; Hägglund L; Bucht A
Chem Biol Interact; 2017 Aug; 273():82-89. PubMed ID: 28601555
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
Taysse L; Dorandeu F; Daulon S; Foquin A; Perrier N; Lallement G; Breton P
Hum Exp Toxicol; 2011 Jun; 30(6):491-8. PubMed ID: 20534641
[TBL] [Abstract][Full Text] [Related]
5. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine.
Taysse L; Daulon S; Delamanche S; Bellier B; Breton P
Hum Exp Toxicol; 2007 Feb; 26(2):135-41. PubMed ID: 17370872
[TBL] [Abstract][Full Text] [Related]
6. Skin decontamination efficacy of sulfur mustard and VX in the pig model: A comparison between Fuller's earth and RSDL.
Dachir S; Cohen M; Buch H; Kadar T
Chem Biol Interact; 2021 Feb; 336():109393. PubMed ID: 33508307
[TBL] [Abstract][Full Text] [Related]
7. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
Mikler J; Tenn C; Worek F; Reiter G; Thiermann H; Garrett M; Bohnert S; Sawyer TW
Toxicol Lett; 2011 Sep; 206(1):47-53. PubMed ID: 21704135
[TBL] [Abstract][Full Text] [Related]
8. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic use of localized cooling in the treatment of VX poisoning.
Sawyer TW; Mikler J; Worek F; Reiter G; Thiermann H; Tenn C; Weatherby K; Bohnert S
Toxicol Lett; 2011 Jul; 204(1):52-6. PubMed ID: 21530621
[TBL] [Abstract][Full Text] [Related]
10. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.
Dalton CH; Hall CA; Lydon HL; Chipman JK; Graham JS; Jenner J; Chilcott RP
J Appl Toxicol; 2015 May; 35(5):543-50. PubMed ID: 25219755
[TBL] [Abstract][Full Text] [Related]
11. Showering effectiveness for human hair decontamination of the nerve agent VX.
Josse D; Wartelle J; Cruz C
Chem Biol Interact; 2015 May; 232():94-100. PubMed ID: 25791764
[TBL] [Abstract][Full Text] [Related]
12. Pickering emulsions for skin decontamination.
Salerno A; Bolzinger MA; Rolland P; Chevalier Y; Josse D; Briançon S
Toxicol In Vitro; 2016 Aug; 34():45-54. PubMed ID: 27021875
[TBL] [Abstract][Full Text] [Related]
13. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
[TBL] [Abstract][Full Text] [Related]
14. In vivo decontamination of the nerve agent VX using the domestic swine model.
Misik J; Pavlik M; Novotny L; Pavlikova R; Chilcott RP; Cabal J; Kuca K
Clin Toxicol (Phila); 2012 Nov; 50(9):807-11. PubMed ID: 22963275
[TBL] [Abstract][Full Text] [Related]
15. Hairy skin exposure to VX in vitro: effectiveness of delayed decontamination.
Rolland P; Bolzinger MA; Cruz C; Josse D; Briançon S
Toxicol In Vitro; 2013 Feb; 27(1):358-66. PubMed ID: 22926045
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four different fuller's earth formulations in skin decontamination.
Roul A; Le CA; Gustin MP; Clavaud E; Verrier B; Pirot F; Falson F
J Appl Toxicol; 2017 Dec; 37(12):1527-1536. PubMed ID: 28745436
[TBL] [Abstract][Full Text] [Related]
17. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
[TBL] [Abstract][Full Text] [Related]
18. RSDL decontamination of human skin contaminated with the nerve agent VX.
Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
[TBL] [Abstract][Full Text] [Related]
20. Immediate post-dosing paralysis following severe soman and VX toxicosis in guinea pigs.
Bide RW; Schofield L; Risk DJ
J Appl Toxicol; 2005; 25(5):410-7. PubMed ID: 16092080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
